Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

interleukin 31 receptor A (A01), Mouse anti-Human, Polyclonal Antibody, Abnova™

Mouse polyclonal antibody raised against a partial recombinant IL31RA.

Supplier:  Abnova Corporation H00133396A01

Catalog No. 89-004-787


Only null left
Add to Cart

Description

Description

IL31RA is related to gp130 (IL6ST; MIM 600694), the common receptor subunit for IL6 (MIM 147620)-type cytokines. Oncostatin M receptor (OSMR; MIM 601743) and IL31RA form the heterodimeric receptor through which IL31 (MIM 609509) signals. Expression of IL31RA and OSMR mRNA is induced in activated monocytes, and both mRNAs are constitutively expressed in epithelial cells (Dillon et al., 2004 [PubMed 15184896]).[supplied by OMIM

Sequence: LPAKPENISCVYYYRKNLTCTWSPGKETSYTQYTVKRTYAFGEKHDNCTTNSSTSENRASCSFFLPRITIPDNYTIEVEAENGDGVIKSHMTYWRLENIA
Specifications

Specifications

interleukin 31 receptor A
Polyclonal
Mouse polyclonal antibody raised against a partial recombinant IL31RA.
IL31RA
CRL/CRL3/GLM-R/GLMR/GPL/IL-31RA/MGC125346/PRO21384
Mouse
50 μL
Apoptosis
Primary
Human
Serum
ELISA, Western Blot
Unconjugated
50% glycerol
NM_139017
IL31RA
IL31RA (NP_620586, 21 a.a. ∼ 120 a.a) partial recombinant protein with GST tag.
RUO
Yes
133396
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.